| http://www.w3.org/ns/prov#value | - 9] which has a binding activity to the cannabinoid type 2 receptor as a nephritis treating agent, [13] the pharmaceutical composition according to any one of [1] to [9]which has a binding activity to the cannabinoid type 2 receptor as an analgesic agent, [14] a compound of the formula (I): wherein R1 is a group represented by the formula: ???Y1???Y2???Y3???Ra wherein Y1, Y2, Y3 and Rb are as defin
|
